The prevention of schizophrenia is not possible, but numerous studies show that certain anomalies of motor development (speech, coordination, social behavior, etc.) suffered by children and young people, and even intrauterine markers, are indications of the existence of the disease. years before it manifests, according to Professor Celso Arango.
Arango, head of the Unit of Adolescents of Psychiatry at the Gregorio Marañón Hospital in Madrid and scientific director of the Center for Biomedical Research in Mental Health Network (CIBERSAM), adds that "there is evidence that shows that schizophrenia is a disease of neurodevelopment."
Early detection is important to provide the necessary support and improve the quality of life of patients and their families, but experts warn that the total or partial withdrawal of medication is a significant problem, since almost forty percent of patients abandon antipsychotic treatment during the first year, and 75 percent do so during the second year, suffering a relapse of the disease between six and twenty-four months after the suppression of the drugs.
New medications for schizophrenia
At present, the treatment of schizophrenia is based on the administration of antipsychotic drugs and psychosocial therapies, but the side effects of these drugs are being analyzed, since there are studies that show that the use of these drugs increases the incidence of Side effects in younger patients.
Therefore, the goal of scientists is to increase investment in research to effectively combat mental disorders such as schizophrenia, as well as reduce the disability they cause, taking into account the needs of the sick.
The cost associated with schizophrenia in Spain represents 2.7% of the total health cost of the National Health System, and it is estimated that this pathology affects one percent of the Spanish population, although only fifty percent of the patients diagnosed receives treatment